Is it possible to define early distal cholangiocarcinoma?

Langenbeck's Archives of Surgery

Volumn 401, Issue 1, 2016, Pages 25-32

  Miura, Fumihiko ^a   Sano, Keiji ^a   Amano, Hodaka ^a   Toyota, Naoyuki ^a   Wada, Keita ^a   Tokairin, Takuo ^b   Kondo, Fukuo ^b   Hayano, Koichi ^c   Matsubara, Hisahiro ^c   Takada, Tadahiro ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TEIKYO UNIVERSITY HOSPITAL   (Japan)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

Distal cholangiocarcinoma; Early cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ADVENTITIA; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; DISTAL CHOLANGIOCARCINOMA; EARLY CANCER; FEASIBILITY STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; JAPANESE (PEOPLE); JAUNDICE; LIVER METASTASIS; LIVER TUMOR; LYMPH NODE METASTASIS; MALE; OVERALL SURVIVAL; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STOMACH TUMOR; SURVIVAL TIME; TUMOR INVASION; VERY ELDERLY; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; EARLY CANCER DIAGNOSIS; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREATICODUODENECTOMY; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84959320512     PISSN: 14352443     EISSN: 14352451     Source Type: Journal    
DOI: 10.1007/s00423-015-1351-6     Document Type: Article

References (31)

1. Murakami Y, Uemura K, Sudo T, Hashimoto Y, Nakashima A, Kondo N, Sakabe R, Ohge H, Sueda T (2011) Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma. Ann Surg Oncol 18(3):651–658
2. Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC (2002) Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 37(6):806–813
3. Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T, Ojima H (2007) Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma. World J Surg 31(10):2016–2022
4. Konstadoulakis MM, Roayaie S, Gomatos IP, Labow D, Fiel MI, Miller CM, Schwartz ME (2008) Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: operative results and long-term outcome. Surgery 143(3):366–374
5. Igami T, Nishio H, Ebata T, Yokoyama Y, Sugawara G, Nimura Y, Nagino M (2010) Surgical treatment of hilar cholangiocarcinoma in the “new era”: the Nagoya University experience. J Hepatobiliary Pancreat Sci 17(4):449–454
6. Lee SG, Song GW, Hwang S, Ha TY, Moon DB, Jung DH, Kim KH, Ahn CS, Kim MH, Lee SK, Sung KB, Ko GY (2010) Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience. J Hepatobiliary Pancreat Sci 17(4):476–489
7. Sakamoto Y, Kosuge T, Shimada K, Sano T, Ojima H, Yamamoto J, Yamasaki S, Takayama T, Makuuchi M (2005) Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins. Surgery 137(4):396–402
8. Hong SM, Pawlik TM, Cho H, Aggarwal B, Goggins M, Hruban RH, Anders RA (2009) Depth of tumor invasion better predicts prognosis than the current American Joint Committee on Cancer T classification for distal bile duct carcinoma. Surgery 146(2):250–257
9. Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira SP, Roughton M, Bridgewater J (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362(14):1273–1281
10. Okusaka T, Nakachi K, Fukutomi A, Mizuno N, Ohkawa S, Funakoshi A, Nagino M, Kondo S, Nagaoka S, Funai J, Koshiji M, Nambu Y, Furuse J, Miyazaki M, Nimura Y (2010) Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. Br J Cancer 103(4):469–474
11. Kato A, Shimizu H, Ohtsuka M, Yoshidome H, Yoshitomi H, Furukawa K, Takeuchi D, Takayashiki T, Kimura F, Miyazaki M (2013) Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single-center study. Ann Surg Oncol 20(1):318–324
12. Tsunoda T, Eto T, Koga M, Tomioka T, Motoshima K, Yamaguchi T, Izawa K, Tsuchiya R (1989) Early carcinoma of the extrahepatic bile duct. Jpn J Surg 19(6):691–698
13. Japanese Society of Biliary Surgery (2004) Classification of biliary tract carcinoma, second English edition. Kanehara & Co., LTD, Tokyo
14. Yamaguchi K (1992) Early bile duct carcinoma. Aust N Z J Surg 62(7):525–529
15. Mizumoto R, Ogura Y, Kusuda T (1993) Definition and diagnosis of early cancer of the biliary tract. Hepatogastroenterol 40(1):69–77
16. Cha JM, Kim MH, Lee SK, Seo DW, Lee SS, Lee JH, Lee SG, Jang SJ (2006) Clinicopathological review of 61 patients with early bile duct cancer. Clin Oncol (R Coll Radiol) 18(9):669–677
17. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2009) Distal bile duct. AJCC cancer staging manual, 7th edn. Springer, New York, pp 227–233
18. Miura F, Sano K, Amano H, Toyota N, Wada K, Yoshida M, Hayano K, Matsubara H, Takada T (2014) Evaluation of portal vein invasion of distal cholangiocarcinoma as borderline resectability. J Hepatobiliary Pancreat Sci 22(4):294–300
19. Hong SM, Kim MJ, Pi DY, Jo D, Cho HJ, Yu E, Ro JY (2005) Analysis of extrahepatic bile duct carcinomas according to the New American Joint Committee on Cancer staging system focused on tumor classification problems in 222 patients. Cancer 104(4):802–810
20. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M (2009) The Clavien–Dindo classification of surgical complications: five-year experience. Ann Surg 250(2):187–196
21. Murakami T (1979) Early cancer of the stomach. World J Surg 3(6):685–692
22. Blechacz B, Komuta M, Roskams T, Gores GJ (2011) Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 8(9):512–522
23. Miyakawa S, Ishihara S, Horiguchi A, Takada T, Miyazaki M, Nagakawa T (2009) Biliary tract cancer treatment: 5,584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in Japan. J Hepatobiliary Pancreat Surg 16(1):1–7
24. Nagakawa T (1999) On the revision of the Japanese general rules for surgical and pathological studies on cancer of the biliary tract. Jpn J Gastroenterol Surg 32(1):69–74 (in Japanese)
25. Hong SM, Presley AE, Stelow EB, Frierson HF Jr, Moskaluk CA (2006) Reconsideration of the histologic definitions used in the pathologic staging of extrahepatic bile duct carcinoma. Am J Surg Pathol 30(6):744–749
26. Ebata T, Nagino M, Nishio H, Igami T, Yokoyama Y, Nimura Y (2007) Pancreatic and duodenal invasion in distal bile duct cancer: paradox in the tumor classification of the American Joint Committee on Cancer. World J Surg 31(10):2008–2015
27. Bahra M, Jacob D, Langrehr JM, Neumann UP, Neuhaus P (2008) Carcinoma of the distal and middle bile duct: surgical results, prognostic factors, and long-term follow-up. J Hepatobiliary Pancreat Surg 15(5):501–507
28. Choi SB, Park SW, Kim KS, Choi JS, Lee WJ (2009) The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection. J Surg Oncol 99(6):335–342
29. Nagahashi M, Shirai Y, Wakai T, Sakata J, Ajioka Y, Nomura T, Tsuchiya Y, Hatakeyama K (2010) Depth of invasion determines the postresectional prognosis for patients with T1 extrahepatic cholangiocarcinoma. Cancer 116(2):400–405
30. Higuchi R, Ota T, Araida T, Kobayashi M, Furukawa T, Yamamoto M (2010) Prognostic relevance of ductal margins in operative resection of bile duct cancer. Surgery 148(1):7–14
31. Kayahara M, Nagakawa T, Ohta T, Kitagawa H, Tajima H, Miwa K (1999) Role of nodal involvement and the periductal soft-tissue margin in middle and distal bile duct cancer. Ann Surg 229(1):76–83